Endometriosis: “2025 objective’ for reimbursement of a saliva test, says Catherine Vautrin. “This is our objective”, but “this requires a final validation by the High Authority of Health’, she said.
ENDOmind judged the test “promising” and “innovative” on the basis of a study involving 1,000 women. But she also underlined the need to “conduct additional studies” before deciding on the advisability or otherwise of long-term reimbursement.